Salix Pharmaceuticals to Present at Three Investment Conferences in May
RALEIGH, N.C.--(BUSINESS WIRE)-- Salix Pharmaceuticals, Ltd. (SLXP) today announced that the Company will present at three investment conferences during May 2012. Information regarding these conferences is provided below:
|Deutsche Bank 37 Annual Health Care Conference|
|Boston, MA||Tuesday, May 8||4:10 p.m. ET|
|JMP Securities Growth Conference|
|San Francisco, CA||Wednesday, May 16||12:30 p.m. ET|
|Bank of America 2012 Health Care Conference|
|Las Vegas, NV||Thursday, May 17||9:40 a.m. ET|
Interested parties can access a live audio web cast of the presentation at http://www.salix.com. A replay of the presentation will be available at the same location.
Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salixs strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Companys gastroenterology specialty sales and marketing team.
Salix trades on the NASDAQ Global Select Market under the ticker symbol SLXP.
For more information, please visit our Website at www.salix.com or contact the Company at 919-862-1000. Follow us on Twitter (@SalixPharma) and Facebook (www.facebook.com/SalixPharma). Information on our Twitter feed, Face book page and web site is not incorporated in our SEC filings.
Salix Pharmaceuticals, Ltd.
Adam C. Derbyshire, 919-862-1000
Executive Vice President
and Chief Financial Officer
G. Michael Freeman, 919-862-1000
Associate Vice President, Investor Relations
and Corporate Communications
Source: Salix Pharmaceuticals, Ltd.Copyright Business Wire 2012